Boston Medical Center (BMC) has recently been named one of the top 50 geriatrics programs in the United States by U.S. News & World Report, marking a significant achievement for the institution. This prestigious recognition highlights BMC’s exemplary leadership in Alzheimer’s care, patient tre
The population of older adults in the United States is growing rapidly, and with it, the need for tailored healthcare solutions is increasing. Diagnostic errors are unfortunately common in this demographic, often due to multiple chronic conditions, polypharmacy, and atypical presentations of
In today's world, maintaining gut health is emerging as a crucial component in the fight against inflammatory diseases such as inflammatory bowel disease (IBD), which encompasses both Crohn's disease and ulcerative colitis. Dr. Victor Chedid, a leading gastroenterologist and IBD expert at
Celiac disease is an autoimmune disorder affecting nearly 1% of the global population. This condition, driven by a harmful reaction to gluten found in wheat, rye, and barley, has seen a doubling in its prevalence over the past 25 years. The dire consequences include damage to the small intestine,
The complexity of Type 2 Diabetes Mellitus (T2DM) has prompted scientists to look beyond traditional factors like diet and genetics to better understand this chronic condition. Emerging research highlights the crucial role of the gut microbiota in T2DM pathogenesis and management. This article
The European pharmaceutical landscape is undergoing significant regulatory and research-driven changes. Vifor Pharma’s recent clash with the European Commission, coupled with groundbreaking diabetes research, marks a pivotal moment for healthcare stakeholders. This article delves into these major d
